Completed
Phase 3
Age: 0 - 1Year
All Genders
ID00000576
Inhaled Beclomethasone to Prevent Chronic Lung Disease
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-02-18
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
To test if inhaled glucocorticoids, early in the course of respiratory failure in premature infants, permit normal lung growth and differentiation, thus preventing development of bronchopulmonary dysplasia.
CONDITIONS
Brief Title
Inhaled Beclomethasone to Prevent Chronic Lung Disease
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here